English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

1Division of Infectious Diseases, Mayo Clinic in Arizona, Phoenix, AZ, USA; 2Department of Internal Medicine, Washington University of St. Louis, St. Louis, MO; 3Division of Gastroenterology and Hepatology Mayo Clinic, Rochester, MN, USA; 5University of Texas Health Science Center; 4Division of Gastroenterology and Nutrition, Loyola University Medical Center, Chicago, IL, USA; 6Hamilton Regional Laboratory Medicine Program, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada, Vancouver Island Health Authority, Victoria, Department of Pathology and Laboratory Medicine, University of British Columbia, BC, Canada; 7Rebioitx, Inc. Roseville, MN; 8BioRankings LLC St. Louis, MO

open forum infectious diseases

RBX2660 is Safe, Superior to Antibiotic-Treated Controls for Preventing Recurrent Clostridium difficile, and May Rehabilitate Patient Microbiomes: Open Label Trial Results